News
A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle ...
National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...
A new Idaho law restricting public benefits for undocumented immigrants is facing a legal challenge. The ACLU of Idaho filed ...
The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), located at Fred Hutch Cancer Center, is a statistical and data management center (SDMC) dedicated to supporting investigators who ...
1d
AllAfrica on MSNHIV/Aids Breakthrough Not a 'Cure', Popular Social Media Posts Misrepresent the FactsHIV/Aids breakthrough not a 'cure', popular social media posts misrepresent the factsIN SHORT: While promising, a recent breakthrough in HIV research is not a "cure" or a "vaccine", as several posts ...
2d
LoveBScott on MSNMistr PrEP, a Modern HIV Protection Platform, Is Saving Lives—let’s Talk About ItBut modern HIV protection platform Mistr PrEP is helping change that — by making protection smarter, easier, and actually ...
This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...
Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results